ABOS vs MTAC
Comparison between Acumen Pharmaceuticals Inc (ABOS, Company) and MedTech Acquisition Corp - Class A (MTAC, Company).
ABOS vs MTAC - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
ABOS
$183M
MTAC
$183M
Max Drawdown
ABOS
95.56%
Winner
MTAC
13.92%
Sharpe Ratio
Winner
ABOS
1.35
MTAC
0.44
5Y Beta
ABOS
1.45
MTAC
N/A
Industry
ABOS
Biotechnology
MTAC
N/A
P/E Ratio
ABOS
-1.40
Winner
MTAC
-32.94
Debt to Equity
ABOS
35.49%
Winner
MTAC
0.00%
Free Cash Flow Yield
ABOS
-57.53%
Winner
MTAC
-27.91%
P/S Ratio
ABOS
538.78
Winner
MTAC
12.43
P/B Ratio
ABOS
2.10
Winner
MTAC
-12.13
ABOS vs MTAC - Historical Returns
Returns include dividend reinvestment.
1M
ABOS
-0.42%
Winner
MTAC
+7.90%
3M
ABOS
-28.18%
Winner
MTAC
+9.99%
6M
Winner
ABOS
+35.43%
MTAC
+11.55%
1Y
Winner
ABOS
+137.00%
MTAC
+14.55%
5Y(CAGR)
ABOS
-35.24%
MTAC
N/A
Max(CAGR)
ABOS
-35.24%
Winner
MTAC
+3.05%
ABOS vs MTAC - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | ABOS | MTAC |
|---|---|---|
| 2026 | +17.33% | N/A |
| 2025 | +14.05% | N/A |
| 2024 | -59.34% | N/A |
| 2023 | -27.00% | +12.84% |
| 2022 | -19.76% | +0.80% |
| 2021 | -66.37% | -6.08% |
ABOS vs MTAC Drawdown Comparison
The maximum drawdown for ABOS was -95.56%, occurring on Apr 17, 2025. This drawdown has not yet recovered.
The maximum drawdown for MTAC was -13.92%, occurring on Mar 7, 2022. Recovery took 622 trading sessions.
The current ABOS drawdown is -88.31%.
| Rank | ABOS | MTAC |
|---|---|---|
| #1 | -95.56% Jul 2, 2021 - Apr 17, 2025 | -13.92% Feb 19, 2021 - Aug 10, 2023 |
| #2 | N/A | -1.90% Feb 8, 2021 - Feb 16, 2021 |
Correlation
Correlation between ABOS and MTAC is -0.24 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.24
-101
Select Stocks to Compare
Popular: ABOS vs SPYMTAC vs SPY
More Comparisons
Compare with similar stocks